David D. Meek

Insider Reports History

Location
West Lafayette, IN
Signature
/s/ Christian Klemt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. Meek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirati Therapeutics, Inc. Chief Executive Officer, Director Common Stock 151K $8.92M $59.02 20 Jan 2023 Direct
uniQure N.V. Director Ordinary Shares 34.2K $494K $14.45 20 Jun 2025 Direct
Mirati Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (Right to Buy) 151K 20 Jan 2023 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 38.5K 12 Jun 2025 Direct
uniQure N.V. Director Stock Option (Right to Buy) 15.6K 11 Jun 2025 Direct
Entasis Therapeutics Holdings Inc. Director Common Stock 0 $2.20 11 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. Director Stock Option (right to buy) 0 11 Jul 2022 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 04 Jun 2024 Direct

Insider Reports Filed by David D. Meek

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QURE uniQure N.V. 20 Jun 2025 1 -$30.5K 4 Director 24 Jun 2025, 17:34
CGEM Cullinan Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:09
QURE uniQure N.V. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:27
QURE uniQure N.V. 19 Jun 2024 2 $0 4 Director 21 Jun 2024, 17:10
QURE uniQure N.V. 13 Jun 2024 1 -$11.4K 4 Director 17 Jun 2024, 19:35
FUSN Fusion Pharmaceuticals Inc. 04 Jun 2024 1 $0 4 Director 04 Jun 2024, 17:25
CGEM Cullinan Therapeutics, Inc. 15 May 2024 1 $0 4 Director 16 May 2024, 17:40
CGEM Cullinan Therapeutics, Inc. 15 May 2024 0 $0 3 Director 16 May 2024, 17:30
FUSN Fusion Pharmaceuticals Inc. 16 Oct 2023 1 $0 4 Director 16 Oct 2023, 17:00
FUSN Fusion Pharmaceuticals Inc. 16 Oct 2023 0 $0 3 Director 16 Oct 2023, 16:51
QURE uniQure N.V. 13 Jun 2023 3 -$43.2K 4 Director 20 Jun 2023, 17:25
QURE uniQure N.V. 27 Feb 2023 1 -$7.67K 4 Director 01 Mar 2023, 15:09
MRTX Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 Chief Executive Officer, Director 24 Jan 2023, 15:00
MRTX Mirati Therapeutics, Inc. 17 Jan 2023 1 -$135K 4 Chief Executive Officer, Director 19 Jan 2023, 08:45
MRTX Mirati Therapeutics, Inc. 19 Dec 2022 2 -$187K 4 Chief Executive Officer, Director 21 Dec 2022, 20:20
ETTX Entasis Therapeutics Holdings Inc. 07 Jul 2022 4 -$109K 4 Director 11 Jul 2022, 16:07
QURE uniQure N.V. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:22
QURE uniQure N.V. 28 Feb 2022 1 -$10.1K 4 Director 02 Mar 2022, 16:34
QURE uniQure N.V. 24 Feb 2022 2 $0 4 Director 28 Feb 2022, 17:27
ETTX Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 Director 19 Jan 2022, 15:01
MRTX Mirati Therapeutics, Inc. 14 Jan 2022 2 $0 4 Chief Executive Officer, Director 18 Jan 2022, 17:20
MRTX Mirati Therapeutics, Inc. 22 Sep 2021 1 $0 4 Chief Executive Officer, Director 24 Sep 2021, 17:11
MRTX Mirati Therapeutics, Inc. 20 Sep 2021 0 $0 3 Chief Executive Officer, Director 24 Sep 2021, 17:10
ETTX Entasis Therapeutics Holdings Inc. 16 Jul 2021 4 $0 4 Director 15 Feb 2022, 15:02